Efficacy and safety of casopitant mesylate, a neurokinin 1 (NK1)-receptor antagonist, in prevention of chemotherapy-induced nausea and vomiting in patients receiving cisplatin-based highly emetogenic chemotherapy: a randomised, double-blind, placebo-controlled trial

Steven M Grunberg, Janusz Rolski, Janos Strausz, Zeba Aziz, Stephen Lane, Mark W Russo, Paul Wissel, Mary Guckert, Oliver Wright, Jørn Herrstedt

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Abstrakt

Udgivelsesdato: 2009-Jun
OriginalsprogEngelsk
TidsskriftLancet Oncology
Vol/bind10
Udgave nummer6
Sider (fra-til)549-58
Antal sider9
ISSN1470-2045
DOI
StatusUdgivet - 1. jun. 2009

    Fingerprint

Citationsformater